N-2-(6-CHLORO-1H-BENZOIMIDAZOL-2-YL)-N-4-(2-DIALLYLAMINO-ETHYL)-6-METHYL-PYRIMIDINE-2,4-DIAMINE
UNII REA49E39XF
Substance Identification & Data
This profile provides standardized clinical and technical data for N-2-(6-chloro-1h-benzoimidazol-2-yl)-n-4-(2-diallylamino-ethyl)-6-methyl-pyrimidine-2,4-diamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) REA49E39XF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 42388-75-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H24ClN7 SASMBUVNGXXJEA-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-2-(6-chloro-1h-benzoimidazol-2-yl)-n-4-(2-diallylamino-ethyl)-6-methyl-pyrimidine-2,4-diamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.